← Back to Search

Phototherapy

Open Label Narrowband UVB phototherapy for Psoriasis

N/A
Recruiting
Research Sponsored by Psoriasis Treatment Center of Central New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

A single center study of 30 patient receiving Narrowband UVB phototherapy three times weekly for 12 weeks. Patients will be evaluated through week 36 to evaluate maintenance of response.

Eligible Conditions
  • Psoriasis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Psoriasis area severity index score
Secondary study objectives
Body Surface Area
Physician's Global Assessments multiplied by Body surface area
Physicians Global Assessment

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Open Label Narrowband UVB phototherapyExperimental Treatment1 Intervention
Open Label Narrowband UVB phototherapy for 12 weeks.

Find a Location

Who is running the clinical trial?

Psoriasis Treatment Center of Central New JerseyLead Sponsor
14 Previous Clinical Trials
412 Total Patients Enrolled
13 Trials studying Psoriasis
372 Patients Enrolled for Psoriasis
~4 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top